Indivior Pharmaceuticals Inc
(INDV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 308,000 | 230,000 | 115,000 | 562,000 | 458,000 |
| Depreciation Amortization | 18,000 | 12,000 | 6,000 | 26,000 | 20,000 |
| Accounts receivable | -2,000 | 2,000 | 26,000 | N/A | -3,000 |
| Accounts payable and accrued liabilities | 131,000 | 89,000 | 64,000 | N/A | -1,000 |
| Other Working Capital | 117,000 | 82,000 | 91,000 | -52,000 | -13,000 |
| Other Operating Activity | -298,000 | -195,000 | -137,000 | -96,000 | -47,000 |
| Operating Cash Flow | $274,000 | $220,000 | $165,000 | $440,000 | $414,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12,000 | -8,000 | N/A | 0 | -1,000 |
| Purchase Sale Intangibles | -4,000 | -4,000 | N/A | N/A | -24,000 |
| Other Investing Activity | -4,000 | -4,000 | 0 | -26,000 | -24,000 |
| Investing Cash Flow | $-16,000 | $-12,000 | $N/A | $-26,000 | $-25,000 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -28,000 | -19,000 | -9,000 | N/A | N/A |
| Dividend Paid | N/A | N/A | N/A | -500,000 | N/A |
| Other Financing Activity | -9,000 | 3,000 | -9,000 | 410,000 | -364,000 |
| Financing Cash Flow | $-37,000 | $-16,000 | $-18,000 | $-90,000 | $-364,000 |
| Exchange Rate Effect | N/A | N/A | -12,000 | 0 | N/A |
| Beginning Cash Position | 331,000 | 331,000 | 331,000 | 7,000 | 7,000 |
| End Cash Position | 552,000 | 523,000 | 466,000 | 331,000 | 32,000 |
| Net Cash Flow | $221,000 | $192,000 | $135,000 | $324,000 | $25,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 274,000 | 220,000 | 165,000 | 440,000 | 414,000 |
| Capital Expenditure | -12,000 | -8,000 | N/A | N/A | -1,000 |
| Free Cash Flow | 262,000 | 212,000 | 165,000 | 440,000 | 413,000 |